Mizrahi, J. D., et al. (2020). Pancreatic cancer. Lancet, 395(10242), 2008–2020.

Article  CAS  PubMed  Google Scholar 

Siegel, R. L., et al. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 17–48.

PubMed  Google Scholar 

Hidalgo, M., et al. (2015). Addressing the challenges of pancreatic cancer: Future directions for improving outcomes. Pancreatology, 15(1), 8–18.

Article  PubMed  Google Scholar 

Schober, M., et al. (2014). Desmoplasia and chemoresistance in pancreatic cancer. Cancers (Basel), 6(4), 2137–2154.

Article  PubMed  Google Scholar 

WHO Classification of Tumours Editorial Board. (2019). Digestive System Tumours: WHO Classification of Tumours, 5th ed. Vol. 1.

Stewart, B. W., et al. (2014). World Cancer Report 2014: World Cancer Reports.

Pishvaian, M. J., & Brody, J. R. (2017). Therapeutic implications of molecular subtyping for pancreatic cancer. Oncology (Williston Park), 31(3), 159–66. 168.

PubMed  Google Scholar 

Fitzgerald, T. L., et al. (2008). Changing incidence of pancreatic neoplasms: A 16-year review of statewide tumor registry. Pancreas, 37(2), 134–138.

Article  PubMed  Google Scholar 

Siegel, R. L., et al. (2022). Cancer statistics, 2022. CA: A Cancer Journal for Clinicians, 72(1), 7–33.

PubMed  Google Scholar 

Gittes, G. K. (2009). Developmental biology of the pancreas: A comprehensive review. Developmental Biology, 326(1), 4–35.

Article  CAS  PubMed  Google Scholar 

Rhim, A. D., et al. (2012). EMT and dissemination precede pancreatic tumor formation. Cell, 148(1–2), 349–361.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Farrell, A. S., et al. (2017). MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance. Nature Communications, 8(1), 1728.

Article  PubMed  PubMed Central  Google Scholar 

Reichert, M., et al. (2018). Regulation of epithelial plasticity determines metastatic organotropism in pancreatic cancer. Developmental Cell, 45(6), 696-711 e8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crawford, H. C., Pasca di Magliano, M., & Banerjee, S. (2019). Signaling networks that control cellular plasticity in pancreatic tumorigenesis, progression, and metastasis. Gastroenterology., 156(7), 2073–2084.

Article  CAS  PubMed  Google Scholar 

Shen, S., & Clairambault, J. (2020). Cell plasticity in cancer cell populations. F1000Res, 9, 635.

Article  CAS  Google Scholar 

Yuan, S., Norgard, R. J., & Stanger, B. Z. (2019). Cellular plasticity in cancer. Cancer Discovery, 9(7), 837–851.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rambow, F., Marine, J. C., & Goding, C. R. (2019). Melanoma plasticity and phenotypic diversity: Therapeutic barriers and opportunities. Genes & Development, 33(19–20), 1295–1318.

Article  CAS  Google Scholar 

Qin, S., et al. (2020). Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduction and Targeted Therapy, 5(1), 228.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kemper, K., et al. (2014). Phenotype switching: Tumor cell plasticity as a resistance mechanism and target for therapy. Cancer Research, 74(21), 5937–5941.

Article  CAS  PubMed  Google Scholar 

Gupta, P. B., et al. (2019). Phenotypic plasticity: Driver of cancer initiation, progression, and therapy resistance. Cell Stem Cell, 24(1), 65–78.

Article  CAS  PubMed  Google Scholar 

Zhuang, X., Zhang, H., & Hu, G. (2019). Cancer and microenvironment plasticity: Double-edged swords in metastasis. Trends in Pharmacological Sciences, 40(6), 419–429.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smigiel, J. M., et al. (2019). Cellular plasticity and metastasis in breast cancer: A pre- and post-malignant problem. Journal of Cancer Metastasis and Treatment, 5, 47.

Contreras-Trujillo, H., et al. (2021). Deciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analyses. Nature Communications, 12(1), 6522.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, M., et al. (2020). An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles. Communications Biology, 3(1), 505.

Article  PubMed  PubMed Central  Google Scholar 

Hinohara, K., & Polyak, K. (2019). Intratumoral heterogeneity: More than just mutations. Trends in Cell Biology, 29(7), 569–579.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun, X. X., & Yu, Q. (2015). Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment. Acta Pharmacologica Sinica, 36(10), 1219–1227.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nabi, K., & Le, A. (2021). The intratumoral heterogeneity of cancer metabolism. Advances in Experimental Medicine and Biology, 1311, 149–160.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao, Z., Dai, Z., & Locasale, J. W. (2019). Metabolic landscape of the tumor microenvironment at single cell resolution. Nature Communications, 10(1), 3763.

Article  PubMed  PubMed Central  Google Scholar 

Lawson, D. A., et al. (2018). Tumour heterogeneity and metastasis at single-cell resolution. Nature Cell Biology, 20(12), 1349–1360.

Article  CAS  PubMed  PubMed Central  Google Scholar 

da Silva-Diz, V., et al. (2018). Cancer cell plasticity: Impact on tumor progression and therapy response. Seminars in Cancer Biology, 53, 48–58.

Article  PubMed  Google Scholar 

Thiery, J. P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nature Reviews Cancer, 2(6), 442–454.

Article  CAS  PubMed  Google Scholar 

Polyak, K., & Weinberg, R. A. (2009). Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nature Reviews Cancer, 9(4), 265–273.

Article  CAS  PubMed  Google Scholar 

Farmer, P., et al. (2009). A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nature Medicine, 15(1), 68–74.

Article  CAS  PubMed  Google Scholar 

Shibue, T., & Weinberg, R. A. (2017). EMT, CSCs, and drug resistance: The mechanistic link and clinical implications. Nature Reviews. Clinical Oncology, 14(10), 611–629.

Article  PubMed  PubMed Central  Google Scholar 

Byers, L. A., et al. (2013). An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clinical Cancer Research, 19(1), 279–290.

Article  CAS  PubMed  Google Scholar 

Horn, L. A., Fousek, K., & Palena, C. (2020). Tumor plasticity and resistance to immunotherapy. Trends in Cancer, 6(5), 432–441.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baccelli, I., et al. (2013). Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nature Biotechnology, 31(6), 539–544.

Article  CAS  PubMed  Google Scholar 

Aktas, B., et al. (2009). Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Research, 11(4), R46.

Article  PubMed  PubMed Central  Google Scholar 

Micalizzi, D. S., et al. (2009). The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. The Journal of Clinical Investigation, 119(9), 2678–2690.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kong, D., Hughes, C. J., & Ford, H. L. (2020). Cellular plasticity in breast cancer progression and therapy. Frontiers in Molecular Biosciences, 7, 72.

Article  CAS  PubMed  PubMed Central  Google Scholar